PKD knockdown mitigates Ang II-induced cardiac hypertrophy and ferroptosis via the JNK/P53 signaling pathway
Open Access
- 14 November 2023
- journal article
- research article
- Published by Elsevier in Cellular Signalling
- Vol. 113, 110974
Abstract
No abstract availableKeywords
Funding Information
- China National Funds for Distinguished Young Scientists (82000239)
This publication has 60 references indexed in Scilit:
- Protein Kinase D Signaling: Multiple Biological Functions in Health and DiseasePhysiology, 2011
- p53 post-translational modification: deregulated in tumorigenesisTrends in Molecular Medicine, 2010
- Molecular distinction between physiological and pathological cardiac hypertrophy: Experimental findings and therapeutic strategiesPharmacology & Therapeutics, 2010
- Angiotensin II revisited: new roles in inflammation, immunology and agingEMBO Molecular Medicine, 2010
- Atorvastatin reverses cardiac remodeling possibly through regulation of Protein Kinase D/Myocyte Enhancer Factor 2D activation in spontaneously hypertensive ratsPharmacological Research, 2010
- Cytoplasmic functions of the tumour suppressor p53Nature, 2009
- Protein Kinase D in the Cardiovascular SystemCirculation Research, 2008
- Post-translational modification of p53 in tumorigenesisNature Reviews Cancer, 2004
- Protein Kinase Cδ Selectively Regulates Protein Kinase D-Dependent Activation of NF-κB in Oxidative Stress SignalingMolecular and Cellular Biology, 2004
- PKCμ prevents CD95-mediated apoptosis and enhances proliferation in pancreatic tumour cellsOncogene, 2003